Comparison Open Lichtenstein Repair and Totally Extraperitoneal Herniorrhaphy
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03820570 |
Recruitment Status :
Completed
First Posted : January 29, 2019
Last Update Posted : January 29, 2019
|
Sponsor:
Uşak University
Information provided by (Responsible Party):
Uşak University
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Brief Summary:
comparison of early and long term results of open lichtenstein repair and totally extraperitoneal herniorrhaphy for primary inguinal hernias.
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Inguinal Hernia | Procedure: hernia repair | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 200 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Comparison of Early and Long Term Outcomes of Open Lichtenstein Repair and Totally Extraperitoneal Herniorrhaphy for Primary Inguinal Hernias |
Actual Study Start Date : | January 1, 2012 |
Actual Primary Completion Date : | January 1, 2015 |
Actual Study Completion Date : | December 1, 2017 |
Arm | Intervention/treatment |
---|---|
Experimental: lichtenstein
hernia repair
|
Procedure: hernia repair
inguinal hernia repair |
Primary Outcome Measures :
- recurrence [ Time Frame: 3 years ]hernia recurrence
Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- inguinal hernia
Exclusion Criteria:
- recurrent hernia
No Contacts or Locations Provided
Responsible Party: | Uşak University |
ClinicalTrials.gov Identifier: | NCT03820570 |
Other Study ID Numbers: |
TEPP |
First Posted: | January 29, 2019 Key Record Dates |
Last Update Posted: | January 29, 2019 |
Last Verified: | January 2019 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Additional relevant MeSH terms:
Hernia Hernia, Inguinal Pathological Conditions, Anatomical Hernia, Abdominal |